Natera, Inc.(NTRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NTRA Natera, Inc.

休市中 04-04 16:00:00 EDT

133.87

-4.84

-3.49%

盘后133.78

-0.09-0.07%

19:18 EDT

最高136.40	最低126.41	成交量324.78万
今开134.16	昨收138.71	日振幅7.20%
总市值180.97亿	流通市值170.98亿	总股本1.35亿
成交额4.33亿	换手率2.54%	流通股本1.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NTRA","market":"US","secType":"STK","nameCN":"Natera, Inc.","latestPrice":133.87,"timestamp":1743796800000,"preClose":138.71,"halted":0,"volume":3247842,"hourTrading":{"tag":"盘后","latestPrice":133.78,"preClose":133.87,"latestTime":"19:18 EDT","volume":26080,"amount":3489018.65,"timestamp":1743808702698},"delay":0,"floatShares":127720001,"shares":135186184,"eps":-1.526852,"marketStatus":"休市中","change":-4.84,"latestTime":"04-04 16:00:00 EDT","open":134.16,"high":136.395,"low":126.4065,"amount":432739512.54378,"amplitude":0.07201,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.526852,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1435809600000,"exchange":"NASDAQ","adjPreClose":138.71,"preHourTrading":{"tag":"盘前","latestPrice":135.25,"preClose":138.71,"latestTime":"09:28 EDT","volume":959657,"amount":133104483.47942,"timestamp":1743773280158},"postHourTrading":{"tag":"盘后","latestPrice":133.78,"preClose":133.87,"latestTime":"19:18 EDT","volume":26080,"amount":3489018.65,"timestamp":1743808702698},"volumeRatio":1.9813988357721282,"impliedVol":0.9589,"impliedVolPercentile":0.9841},"requestUrl":"/m/hq/s/NTRA/tweets","defaultTab":"tweets","newsList":[{"id":"2519857108","title":"Natera(NTRA.US)获加拿大皇家银行首次覆盖，给予优于大市评级, 目标价251.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2519857108","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2519857108?lang=zh_cn&edition=full","pubTime":"2025-03-14 01:05","pubTimestamp":1741885501,"startTime":"0","endTime":"0","summary":"Natera(NTRA.US)获加拿大皇家银行首次覆盖，给予优于大市评级, 目标价251.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/14010548732286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NTRA"],"gpt_icon":0},{"id":"2517017626","title":"Piper Sandler：维持Natera(NTRA.US)评级，由增持调整至增持评级, 目标价由200.00美元调整至205.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517017626","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517017626?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:02","pubTimestamp":1741107763,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Natera(NTRA.US)评级，由增持调整至增持评级, 目标价由200.00美元调整至205.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05010248524007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NTRA"],"gpt_icon":0},{"id":"2514232708","title":"Baird：维持Natera(NTRA.US)评级，由优于大市调整至优于大市评级, 目标价由183.00美元调整至188.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514232708","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514232708?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:28","pubTimestamp":1740752886,"startTime":"0","endTime":"0","summary":"Baird：维持Natera(NTRA.US)评级，由优于大市调整至优于大市评级, 目标价由183.00美元调整至188.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28222848467014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NTRA"],"gpt_icon":0},{"id":"1132429857","title":"Natera 2024年第四季度GAAP每股收益 $(0.41) 超预期，销售额 $4.761亿超预期 $4.2855亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1132429857","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132429857?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:10","pubTimestamp":1740690630,"startTime":"0","endTime":"0","summary":"Natera报告季度每股亏损 $，超出分析师普遍预期的 $，超出2.38%。与去年同期销售额 $3.111亿相比，增长了53.04%。以上内容来自Benzinga Earnings专栏，原文如下：Natera  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 2.38 percent. This is a 36.92 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $476.10 million which beat the analyst consensus estimate of $428.55 million by 11.10 percent.  This is a 53.04 percent increase over sales of $311.10 milli","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Natera 2024年第四季度GAAP每股收益 $(0.41) 超预期，销售额 $4.761亿超预期 $4.2855亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTRA"],"gpt_icon":0},{"id":"2507425624","title":"Natera, Inc.盘中异动 大幅上涨5.06%报176.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507425624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507425624?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:54","pubTimestamp":1738248880,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时54分，Natera, Inc.股票出现波动，股价急速拉升5.06%。截至发稿，该股报176.73美元/股，成交量33.0423万股，换手率0.25%，振幅4.15%。Natera, Inc.股票所在的生命科学行业中，整体涨幅为4.20%。Natera, Inc.公司简介：Natera Inc 是一家诊断和研究公司，拥有专有的分子和生物信息学技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225440abbd50e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","NTRA","BK4139","LU1988902786.USD","LU0053671581.USD","LU2065731478.USD","LU0106261612.USD","LU0012050646.USD","LU1064131342.USD","LU2264538146.SGD","LU2065169927.USD"],"gpt_icon":0},{"id":"2507254818","title":"高盛：维持Natera(NTRA.US)评级，由买入调整至买入评级, 目标价由160.00美元调整至190.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507254818","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507254818?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:58","pubTimestamp":1738079888,"startTime":"0","endTime":"0","summary":"高盛：维持Natera(NTRA.US)评级，由买入调整至买入评级, 目标价由160.00美元调整至190.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/28235847883310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NTRA"],"gpt_icon":0},{"id":"2506182418","title":"Market Sentiment Around Loss-Making Natera, Inc. (NASDAQ:NTRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2506182418","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506182418?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:07","pubTimestamp":1737731227,"startTime":"0","endTime":"0","summary":"Natera, Inc. ( NASDAQ:NTRA ) is possibly approaching a major achievement in its business, so we would like to shine...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"围绕亏损的Natera，Inc.（纳斯达克：NTRA）的市场情绪","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/market-sentiment-around-loss-making-natera-inc-nasdaqntra","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B3QW5Z07.USD","LU0012050646.USD","LU1988902786.USD","MNQmain","QLD","LU2210149790.SGD","BK4588","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4112","USJW.SI","LU2210150020.SGD","LU2065731478.USD","LU2065171402.SGD","LU2264538146.SGD","USAW.SI","SQQQ","NQmain","BK4585","NTRA","LU2095319765.USD","IE00BGHQF748.EUR",".IXIC","QID","LU1064131342.USD","PSQ","LU2065171311.SGD","TSYW.SI","NVIW.SI","BK4139","LU2065169927.USD","LU0053671581.USD","TQQQ","NDAQ","LU0106261612.USD","LU2065170008.USD"],"gpt_icon":1},{"id":"2505499060","title":"Natera(NTRA.US)获巴克莱首次覆盖，给予增持评级, 目标价200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505499060","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505499060?lang=zh_cn&edition=full","pubTime":"2025-01-24 01:12","pubTimestamp":1737652360,"startTime":"0","endTime":"0","summary":"Natera(NTRA.US)获巴克莱首次覆盖，给予增持评级, 目标价200.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/24011247770023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NTRA"],"gpt_icon":0},{"id":"2505785465","title":"Natera, Inc.盘中异动 下午盘股价大涨5.02%报166.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505785465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505785465?lang=zh_cn&edition=full","pubTime":"2025-01-22 03:29","pubTimestamp":1737487768,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日03时29分，Natera, Inc.股票出现异动，股价大幅拉升5.02%。截至发稿，该股报166.31美元/股，成交量102.403万股，换手率0.78%，振幅7.00%。Natera, Inc.股票所在的生命科学行业中，整体涨幅为2.44%。Natera, Inc.公司简介：Natera Inc 是一家诊断和研究公司，拥有专有的分子和生物信息学技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122032928a22a946e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","LU0053671581.USD","LU2264538146.SGD","LU0012050646.USD","LU0106261612.USD","LU2065170008.USD","LU1988902786.USD","LU1064131342.USD","NTRA","LU2065169927.USD","LU2065731478.USD","LU2065171402.SGD","BK4139"],"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启，投资机会如何掘金？","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启，有哪些投资机会可以布局？值得一提的是，科技股在特朗普任期内表现尤为突出，成为推动美股上涨的主要力量。在特朗普第一个任期内，美元整体表现相对弱势。4年任期内，美元指数累计下跌了10.53%。而纵观全球市场，在特朗普上一任期内，恒生科技指数涨幅超过147%，表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4086","TECH","MEDP","AMAT","WBA","LU2065731478.USD","HOLX","APA","SAIA","NQmain","GMAB","LKQ","TSLA","FYBR","LIN","INTC","TER","CSX","PLTR","BK4561","SFM","ALAB","GILD","BK4581","NFLX","FOXA","FCNCA","BRKR","CFLT","HOOD","LECO","MTCH","CCEP","FTAI","ADSK","CDW","DOX","GTLB","ITCI","MELI","PARA","AFRM","PCVX","QRVO","SEIC","RVMD","BSY","CPB","NBIX","TCOM","RKLB","NTES","ENTG","MDB","AEP","CASY","LAMR","MNST","TQQQ","CYBR","AVGO","EXPE","ESLT","CG","AAL","BPOP","HQY","KHC","CHKP","GOOGL","DOCU","MANH","EBAY","QXO","LU1815336091.USD","REG","LULU","DKNG","PODD","SSNC","EVRG","DUOL","ERIE","FWONK","MPWR","NWSA","PSQ","ROIV","BK4550","RGLD","TSEM","AAON","COKE","SQQQ","ZS","SBUX","ALNY","PFG","BK4585","META","NTAP","RYAAY","EA","INCY","LPLA","MRNA","WWD","CSWI","PTC","AZN","TEAM","ARM","CSGP","MKSI","EWBC","GEN","WTFC","NVIW.SI","WDC","CHRD","OTEX","STLD","DSGX","BK4588","EXAS","AMZN","QCOM","BKR","HLNE","TPG","FAST","NTNX","OLED","SBAC","STX","ADBE","CDNS","OKTA","TSCO","TW","RGEN","FTNT","DLTR","ILMN","AAPL","ALGN","ANSS","COO","NICE","NVDA","CBSH","LNW","EXE","NDAQ","ISRG","PCAR","MMYT","ROST","FFIV","LNT","SIRI","CRWD","PAYX","CTSH","Z","JKHY","SOFI","INTU","CEG","JBHT","MSFT","AKAM","FRPT","ON","PCTY","REGN","MCHP","BIIB","RIVN","CWST","ENPH","TLN","TTEK","MARA","RADX","BMRN","SNPS","CTAS","RPRX","CHRW","PDD","LSTR","ULTA","HTHT","AXON","NDSN","PEP","BPMC","MDLZ","ZM","GNTX","ASML","NVMI","ODFL","CSCO","HON","BKNG","JD","LOGI","MNDY","HBAN","ROP","COIN","CPRT","MIDD","NTRA","ERIC","LU0757428866.USD","GRAB","POOL","TMUS","KDP","MTSI","WYNN","CHDN","TRMB","FOX","USAW.SI","BK4593","FSLR","TTWO","AUR","DDOG","TSYW.SI","PNFP","CME","CZR","EQIX","USJW.SI","TROW","DPZ","SMCI","COST","DASH","IDXX","MRVL","LSCC","AMGN","CHTR","NXPI","CINF","MNQmain","LI","ROKU","AMD","QID","ORLY","HSIC","SWKS","BK4534","FSV","INSM","QQQ","SRPT","TXN","ADI","LU0053671581.USD","PAA","MKTX","FER","HST","ICLR","ONC","QLD","AGNC","ARGX","GEHC","GLPI","NTRS",".IXIC","TTD"],"gpt_icon":1},{"id":"2504167168","title":"Natera, Inc.盘中异动 早盘股价大跌5.14%报159.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504167168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504167168?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:57","pubTimestamp":1737125873,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时57分，Natera, Inc.股票出现异动，股价急速下跌5.14%。截至发稿，该股报159.84美元/股，成交量20.4271万股，换手率0.15%，振幅5.54%。Natera, Inc.股票所在的生命科学行业中，整体跌幅为0.14%。Natera, Inc.公司简介：Natera Inc 是一家诊断和研究公司，拥有专有的分子和生物信息学技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011722575396079ebd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1988902786.USD","LU0012050646.USD","LU2264538146.SGD","LU2065170008.USD","NTRA","LU1064131342.USD","LU2065169927.USD","LU2065731478.USD","LU2065171311.SGD","BK4139","LU2065171402.SGD","LU0053671581.USD","LU0106261612.USD"],"gpt_icon":0},{"id":"2504169979","title":"Guggenheim：维持Natera(NTRA.US)评级，由买入调整至买入评级, 目标价由170.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2504169979","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504169979?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:11","pubTimestamp":1737123108,"startTime":"0","endTime":"0","summary":"Guggenheim：维持Natera(NTRA.US)评级，由买入调整至买入评级, 目标价由170.00美元调整至200.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/17221147576704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NTRA"],"gpt_icon":0},{"id":"2503532160","title":"Natera, Inc.盘中异动 下午盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503532160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503532160?lang=zh_cn&edition=full","pubTime":"2025-01-14 03:25","pubTimestamp":1736796341,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日03时25分，Natera, Inc.股票出现波动，股价快速跳水5.02%。截至发稿，该股报166.22美元/股，成交量113.596万股，换手率0.86%，振幅9.52%。Natera, Inc.股票所在的生命科学行业中，整体涨幅为2.55%。其相关个股中，Neuronetics, Inc.、Mainz Biomed N.V.、Prenetics Global涨幅较大，Bioaffinity Technologies, Inc.、Neuronetics, Inc.、Ispecimen Inc.较为活跃，换手率分别为19.67%、14.77%、5.00%，振幅较大的相关个股有Neuronetics, Inc.、Atlantic International Corp.、Castle Biosciences, Inc.，振幅分别为60.88%、23.38%、17.52%。Natera, Inc.公司简介：Natera Inc 是一家诊断和研究公司，拥有专有的分子和生物信息学技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114032541aba97691&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1988902786.USD","LU0012050646.USD","LU2264538146.SGD","LU2065170008.USD","NTRA","LU1064131342.USD","LU2065169927.USD","LU2065731478.USD","LU2065171311.SGD","BK4139","LU2065171402.SGD","LU0053671581.USD","LU0106261612.USD"],"gpt_icon":0},{"id":"2502940813","title":"伯恩斯坦研究公司：维持Natera(NTRA.US)评级，由优于大市调整至优于大市评级, 目标价由160.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502940813","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502940813?lang=zh_cn&edition=full","pubTime":"2025-01-11 02:31","pubTimestamp":1736533861,"startTime":"0","endTime":"0","summary":"伯恩斯坦研究公司：维持Natera(NTRA.US)评级，由优于大市调整至优于大市评级, 目标价由160.00美元调整至200.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/11023147364956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NTRA"],"gpt_icon":0},{"id":"2500611313","title":"Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Natera (NTRA) and Neumora Therapeutics, Inc. (NMRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500611313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500611313?lang=zh_cn&edition=full","pubTime":"2025-01-03 21:10","pubTimestamp":1735909813,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Jazz Pharmaceuticals (JAZZ – Research Report), Nater...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jazz-pharmaceuticals-jazz-natera-ntra-and-neumora-therapeutics-inc-nmra?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"分析师提供对医疗保健公司的见解：Jazz Pharmaceuticals(JAZZ)、Natera(NTRA)和Neumora Therapeutics,Inc.(NMRA)","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jazz-pharmaceuticals-jazz-natera-ntra-and-neumora-therapeutics-inc-nmra?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JAZZ","LU0320765992.SGD","NMRA","BK4533","LU1064131342.USD","LU0053671581.USD","LU1988902786.USD","LU2065169927.USD","NTRA","LU2264538146.SGD","LU2065170008.USD","LU2065171311.SGD","LU0109394709.USD","LU0012050646.USD","BK4007","BK4532","LU2065731478.USD","LU0106261612.USD","BK4137","LU0889565916.HKD","LU2065171402.SGD","HCSG"],"gpt_icon":0},{"id":"2500912321","title":"Natera price target raised to $180 from $165 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2500912321","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500912321?lang=zh_cn&edition=full","pubTime":"2025-01-03 19:30","pubTimestamp":1735903815,"startTime":"0","endTime":"0","summary":"Canaccord raised the firm’s price target on Natera (NTRA) to $180 from $165 and keeps a Buy rating on the shares. The firm previewed its coverage i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/natera-price-target-raised-to-180-from-165-at-canaccord?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"Canaccord将Natera目标价从165美元上调至180美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/natera-price-target-raised-to-180-from-165-at-canaccord?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTRA"],"gpt_icon":0},{"id":"2492615585","title":"Natera, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492615585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492615585?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:58","pubTimestamp":1734551928,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时58分，Natera, Inc.股票出现波动，股价大幅下跌5.02%。Natera, Inc.股票所在的生命科学行业中，整体跌幅为1.67%。其相关个股中，Volitionrx Limited、安奈特保险、Ispecimen Inc.涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、Inotiv, Inc.较为活跃，换手率分别为36.75%、17.74%、15.57%，振幅较大的相关个股有Prenetics Global Limited C/Wts 18/05/2027 、Bioaffinity Technologies Inc C/Wts 07/09/2027 、Ispecimen Inc.，振幅分别为29.29%、23.79%、23.19%。Natera, Inc.公司简介：Natera Inc 是一家诊断和研究公司，拥有专有的分子和生物信息学技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903584895ea59af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","LU0053671581.USD","LU2065171311.SGD","BK4139","LU2065171402.SGD","LU2065169927.USD","NTRA","LU2065170008.USD"],"gpt_icon":0},{"id":"2492954031","title":"Natera expands patent infringement lawsuit against NeoGenomics","url":"https://stock-news.laohu8.com/highlight/detail?id=2492954031","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492954031?lang=zh_cn&edition=full","pubTime":"2024-12-17 21:10","pubTimestamp":1734441047,"startTime":"0","endTime":"0","summary":"Natera (NTRA) announced an expansion of its patent infringement lawsuit against NeoGenomics (NEO) related to its RaDaR tests. On December 10, the D...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/natera-expands-patent-infringement-lawsuit-against-neogenomics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"Natera扩大对NeoGenomics的专利侵权诉讼","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/natera-expands-patent-infringement-lawsuit-against-neogenomics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","LU0106261612.USD","BK4196","NTRA","NEO","LU2065731478.USD","LU2065169927.USD","LU0012050646.USD","LU2065170008.USD","BK4139","LU2065171311.SGD","LU2065171402.SGD","LU0053671581.USD"],"gpt_icon":0},{"id":"2491321801","title":"Natera price target raised to $200 from $160 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2491321801","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491321801?lang=zh_cn&edition=full","pubTime":"2024-12-13 20:11","pubTimestamp":1734091860,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Rachel Vatnsdal raised the firm’s price target on Natera (NTRA) to $200 from $160 and keeps an Overweight rating on the shares. Th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/natera-price-target-raised-to-200-from-160-at-jpmorgan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"摩根大通将Natera目标价从160美元上调至200美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/natera-price-target-raised-to-200-from-160-at-jpmorgan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTRA"],"gpt_icon":0},{"id":"2489429491","title":"Bespoke的‘简单至上’策略：如何超越市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2489429491","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489429491?lang=zh_cn&edition=full","pubTime":"2024-12-07 08:51","pubTimestamp":1733532662,"startTime":"0","endTime":"0","summary":"在波动不断的股市中，Bespoke Investment Group认为，保持简单竟然能出奇制胜。Bespoke选择了Russell 1000指数作为其股票池，并设定了三个筛选标准：正向的股价动能、上升的利润率以及拥有护城河，即具有某种竞争优势，使得公司在一定程度上免受竞争威胁。“我们想提出一套非常简单的标准，”Bespoke Investment Group联合创始人Paul Hickey表示。Bespoke的20只股票组合在过去三个月上涨了13.6%，而Russell 1000指数同期上涨了8.8%。Meta在2024年也表现强劲，股价上涨超过70%。临床基因检测公司Natera同样获得Bespoke青睐。","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2024/12/weixin/one_20241207085120784.png","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2024/12/weixin/one_20241207085120784.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/07085146129316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1923623000.USD","LU2108987350.USD","IE0004086264.USD","MO","BK4141","GB00BDT5M118.USD","NTRA","SG9999017495.SGD","LU0795875169.SGD","LU0211328371.USD","LU0868494617.USD","NVDS.UK","LU0124676726.USD","META","LU1571399168.USD","NVDA","NVDD","LU0823434583.USD","3NVD.UK","LU0215105999.USD","IE00BK4W5L77.USD","2NVD.UK","NVDX","LU1244550577.SGD","NVDY","NVD3.UK","IE00BFSS8Q28.SGD","LU2552382215.SGD","LU0820561818.USD","LU0077335932.USD","LU0265550359.USD","LU0096362180.USD","HK0000320264.USD","LU1712237335.SGD","LU1732799900.SGD","LU2092937148.SGD","LU0353189763.USD","NVDU","SNVD.UK","IE00BJJMRY28.SGD","SG9999014559.SGD","LU2360106780.USD","NVD2.UK","BK4581","LU0234572021.USD","LU1035775433.USD","NVD","NVDS","LU0225283273.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.natera.com","stockEarnings":[{"period":"1week","weight":-0.07},{"period":"1month","weight":-0.095},{"period":"3month","weight":-0.2013},{"period":"6month","weight":0.031},{"period":"1year","weight":0.4494},{"period":"ytd","weight":-0.1543}],"compareEarnings":[{"period":"1week","weight":-0.0907},{"period":"1month","weight":-0.1334},{"period":"3month","weight":-0.1464},{"period":"6month","weight":-0.1182},{"period":"1year","weight":-0.0152},{"period":"ytd","weight":-0.1379}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Natera, Inc.于2007年1月在特拉华州成立。该公司是一家诊断公司，拥有专有的分子和生物信息技术，该公司正在应用该技术来改变全球范围内的疾病管理。该公司的无细胞DNA（CFDNA）技术结合了新颖的分子分析方法，这些方法可以从小到单个细胞的样本中可靠地测量整个基因组中的许多信息区域，以及统计算法，这些算法结合了更广泛的科学界提供的数据，以高精度和高覆盖率识别涵盖广泛严重疾病的遗传变异。该公司的目标是使个性化基因检测和诊断成为保护健康的护理标准的一部分，并告知更早和更有针对性的干预措施，以帮助实现更长寿、更健康的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.020548},{"month":2,"riseRate":0.6,"avgChangeRate":0.03105},{"month":3,"riseRate":0.5,"avgChangeRate":0.006098},{"month":4,"riseRate":0.6,"avgChangeRate":0.024227},{"month":5,"riseRate":0.777778,"avgChangeRate":0.104636},{"month":6,"riseRate":0.777778,"avgChangeRate":0.123586},{"month":7,"riseRate":0.444444,"avgChangeRate":0.024631},{"month":8,"riseRate":0.8,"avgChangeRate":0.142568},{"month":9,"riseRate":0.4,"avgChangeRate":-0.05009},{"month":10,"riseRate":0.3,"avgChangeRate":-0.065647},{"month":11,"riseRate":0.5,"avgChangeRate":0.090493},{"month":12,"riseRate":0.4,"avgChangeRate":0.003242}],"exchange":"NASDAQ","name":"Natera, Inc.","nameEN":"Natera"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Natera, Inc.(NTRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Natera, Inc.(NTRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Natera, Inc.,NTRA,Natera, Inc.股票,Natera, Inc.股票老虎,Natera, Inc.股票老虎国际,Natera, Inc.行情,Natera, Inc.股票行情,Natera, Inc.股价,Natera, Inc.股市,Natera, Inc.股票价格,Natera, Inc.股票交易,Natera, Inc.股票购买,Natera, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Natera, Inc.(NTRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Natera, Inc.(NTRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}